Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does PCI reduce the occurrence of 'hard' clinical endpoints in patients with stable coronary artery disease?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 624–625 (2005)Cite this article

boxed-textKatritsis DG and Ioannidis JPA (2005) Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 111: 2906–2912

Percutaneous revascularization of nonacute coronary disease patients at low clinical risk will improve symptoms and quality of life, but should not be expected to improve survival or freedom from myocardial infarction

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Berger PB et al. (2001) Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy: results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 38: 1440–1449

    Article  CAS  Google Scholar 

  2. Van Belle E et al. (2001) Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 103: 1218–1224

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Medicine at the Mayo Clinic College of Medicine, Rochester, MN

    Verghese Mathew

  2. Director of Cardiovascular Clinical Trials at the Mount Sinai Cardiovascular Institute, New York, NY, USA

    Michael E Farkouh

Authors
  1. Verghese Mathew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael E Farkouh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Verghese Mathew.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathew, V., Farkouh, M. Does PCI reduce the occurrence of 'hard' clinical endpoints in patients with stable coronary artery disease?. Nat Rev Cardiol 2, 624–625 (2005). https://doi.org/10.1038/ncpcardio0377

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0377

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing